Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew R Tee

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Cancers|January 6, 2018
Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer ProgressionEllie Rad, James T Murray, Andrew R Tee
The Journal of Biological Chemistry|January 19, 2002
The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sitesTerence P Herbert, Andrew R Tee, Christopher G Proud
The Biochemical Journal|March 4, 2003
Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availabilityAnne Beugnet, Andrew R Tee, Peter M Taylor, et al.
Seminars in Cell & Developmental Biology|February 7, 2016
The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complexAndrew R Tee, Julian R Sampson, Deb K Pal, et al.
Cellular Signalling|March 11, 2009
Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognitionElaine A Dunlop, Kayleigh M Dodd, Lyndsey A Seymour, et al.
Current Biology : CB|August 9, 2003
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward RhebAndrew R Tee, Brendan D Manning, Philippe P Roux, et al.
Current Biology : CB|February 8, 2022
Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward RhebAndrew R Tee, Brendan D Manning, Philippe P Roux, et al.
FEBS Letters|December 17, 2002
Localisation and regulation of the eIF4E-binding protein 4E-BP3Miranda Kleijn, Gert C Scheper, Mary L Wilson, et al.
Molecular Cell|August 2, 2002
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathwayBrendan D Manning, Andrew R Tee, M Nicole Logsdon, et al.
Oncotarget|April 19, 2017
Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cellsElaine A Dunlop, Charlotte E Johnson, Marie Wiltshire, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Cancers|January 6, 2018
Oncogenic Signalling through Mechanistic Target of Rapamycin (mTOR): A Driver of Metabolic Transformation and Cancer ProgressionEllie Rad, James T Murray, Andrew R Tee
The Journal of Biological Chemistry|January 19, 2002
The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sitesTerence P Herbert, Andrew R Tee, Christopher G Proud
The Biochemical Journal|March 4, 2003
Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availabilityAnne Beugnet, Andrew R Tee, Peter M Taylor, et al.
Seminars in Cell & Developmental Biology|February 7, 2016
The role of mTOR signalling in neurogenesis, insights from tuberous sclerosis complexAndrew R Tee, Julian R Sampson, Deb K Pal, et al.
Cellular Signalling|March 11, 2009
Mammalian target of rapamycin complex 1-mediated phosphorylation of eukaryotic initiation factor 4E-binding protein 1 requires multiple protein-protein interactions for substrate recognitionElaine A Dunlop, Kayleigh M Dodd, Lyndsey A Seymour, et al.
Current Biology : CB|August 9, 2003
Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward RhebAndrew R Tee, Brendan D Manning, Philippe P Roux, et al.
Current Biology : CB|February 8, 2022
Tuberous Sclerosis Complex Gene Products, Tuberin and Hamartin, Control mTOR Signaling by Acting as a GTPase-Activating Protein Complex toward RhebAndrew R Tee, Brendan D Manning, Philippe P Roux, et al.
FEBS Letters|December 17, 2002
Localisation and regulation of the eIF4E-binding protein 4E-BP3Miranda Kleijn, Gert C Scheper, Mary L Wilson, et al.
Molecular Cell|August 2, 2002
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathwayBrendan D Manning, Andrew R Tee, M Nicole Logsdon, et al.
Oncotarget|April 19, 2017
Targeting protein homeostasis with nelfinavir/salinomycin dual therapy effectively induces death of mTORC1 hyperactive cellsElaine A Dunlop, Charlotte E Johnson, Marie Wiltshire, et al.
Pageof 7